Trend Following
(11)
▼
Momentum
(6)
▼
Volatility
(5)
▼
Pattern Recognition
(5)
▼
Mean Reversion
(4)
▼
Volume Based
(5)
▼
Advanced
(10)
▼
CYPH
$0.6327
$
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.
Next Earnings
2026-02-25
Beta
-0.195
Average Volume
Market Cap
Last Dividend
CIK
0001509745
ISIN
US52187K2006
CUSIP
52187K200
CEO
Douglas E. Onsi
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
52
IPO Date
2017-01-25
Status
Active
Latest News
| Title | Headline | Publisher | Date |
|---|---|---|---|
| Cypherpunk Adds Arjun Khemani as Strategic Advisor | CAMBRIDGE, Mass., Jan. 22, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), the privacy technology company, today announced that Arjun Khemani has joined the company as a Strategic Advisor. | PRNewsWire | 2026-01-22 07:00:00 |
| Cypherpunk Accelerates Zcash Accumulation; Increases Treasury Holdings to 290,062.67 ZEC | CAMBRIDGE, Mass., Dec. 30, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), the privacy-focused technology company, today announced a significant expansion of its corporate treasury. | PRNewsWire | 2025-12-30 07:00:00 |
| Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor | CAMBRIDGE, Mass. , Dec. 19, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced that Josh Swihart, Chief Executive Officer of Electric Coin Company (ECC), has joined the company as a Strategic Advisor. | PRNewsWire | 2025-12-19 07:00:00 |
| Cypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call Prepared Remarks Transcript | Cypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call Prepared Remarks Transcript | Seeking Alpha | 2025-12-15 12:59:32 |
| Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor | CAMBRIDGE, Mass. , Dec. 9, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced that industry pioneer Zooko Wilcox, the founder of Zcash, former CEO of the Electric Coin Company, and current Chief Product Officer of Shielded Labs, has joined the company as a Strategic Advisor. | PRNewsWire | 2025-12-09 07:00:00 |
SEC Filings
| Type | Filing Date | Accepted Date | Link |
|---|---|---|---|
| SC 13G/A | 2026-02-12 | 2026-02-12 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 4 | 2025-12-30 | 2025-12-30 | View Filing |
| 8-K | 2025-12-30 | 2025-12-30 | View Filing |
| 8-K | 2025-12-30 | 2025-12-30 | View Filing |
| S-8 | 2025-12-23 | 2025-12-23 | View Filing |
| 8-K | 2025-12-16 | 2025-12-16 | View Filing |
| SC 13D/A | 2025-11-21 | 2025-11-21 | View Filing |
| 4 | 2025-11-21 | 2025-11-21 | View Filing |
| 3 | 2025-11-21 | 2025-11-21 | View Filing |
| 3 | 2025-11-20 | 2025-11-20 | View Filing |
| 8-K | 2025-11-20 | 2025-11-20 | View Filing |
| 4 | 2025-11-19 | 2025-11-19 | View Filing |
| 4 | 2025-11-19 | 2025-11-19 | View Filing |
| DEFA14A | 2025-11-19 | 2025-11-19 | View Filing |
| 4 | 2025-11-19 | 2025-11-19 | View Filing |
| 8-K | 2025-11-18 | 2025-11-18 | View Filing |
| SC 13G | 2025-11-18 | 2025-11-18 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 4 | 2025-11-13 | 2025-11-13 | View Filing |
| 3 | 2025-11-13 | 2025-11-13 | View Filing |
| DEFA14A | 2025-11-12 | 2025-11-12 | View Filing |
| 8-K | 2025-11-12 | 2025-11-12 | View Filing |
| 424B5 | 2025-11-12 | 2025-11-12 | View Filing |
| 10-Q | 2025-11-12 | 2025-11-12 | View Filing |
| 8-K | 2025-11-12 | 2025-11-12 | View Filing |
| DEFA14A | 2025-11-03 | 2025-11-03 | View Filing |
| DEF 14A | 2025-11-03 | 2025-11-03 | View Filing |
| PRE 14A | 2025-10-24 | 2025-10-24 | View Filing |
| SC 13D | 2025-10-16 | 2025-10-16 | View Filing |
| 8-K | 2025-10-09 | 2025-10-09 | View Filing |
| 8-K | 2025-10-06 | 2025-10-06 | View Filing |
| 8-K | 2025-09-11 | 2025-09-11 | View Filing |
| SC 13G/A | 2025-08-14 | 2025-08-14 | View Filing |
| 8-K | 2025-08-14 | 2025-08-14 | View Filing |
| 10-Q | 2025-08-14 | 2025-08-14 | View Filing |
| 4 | 2025-07-01 | 2025-07-01 | View Filing |
| 4 | 2025-07-01 | 2025-07-01 | View Filing |
| 4 | 2025-07-01 | 2025-07-01 | View Filing |
| 8-K | 2025-06-23 | 2025-06-23 | View Filing |
| 8-K | 2025-05-13 | 2025-05-13 | View Filing |
| 10-Q | 2025-05-13 | 2025-05-13 | View Filing |
| ARS | 2025-04-28 | 2025-04-25 | View Filing |
| DEFA14A | 2025-04-28 | 2025-04-25 | View Filing |
| DEF 14A | 2025-04-28 | 2025-04-25 | View Filing |
| 4 | 2025-04-01 | 2025-04-01 | View Filing |
| 4 | 2025-04-01 | 2025-04-01 | View Filing |
| 4 | 2025-04-01 | 2025-04-01 | View Filing |
| 4 | 2025-04-01 | 2025-04-01 | View Filing |
| 4 | 2025-04-01 | 2025-04-01 | View Filing |
| 4 | 2025-04-01 | 2025-04-01 | View Filing |
| 4 | 2025-04-01 | 2025-04-01 | View Filing |
| S-8 | 2025-03-26 | 2025-03-26 | View Filing |
| 10-K | 2025-03-26 | 2025-03-26 | View Filing |
| 8-K | 2025-03-26 | 2025-03-26 | View Filing |
| 8-K | 2025-03-17 | 2025-03-17 | View Filing |
| SC 13G/A | 2025-02-14 | 2025-02-14 | View Filing |
| 8-K | 2025-01-28 | 2025-01-28 | View Filing |
| 4 | 2024-11-15 | 2024-11-15 | View Filing |
| 4 | 2024-11-15 | 2024-11-15 | View Filing |
| 4 | 2024-11-15 | 2024-11-15 | View Filing |
| 4 | 2024-11-15 | 2024-11-15 | View Filing |
| SC 13G | 2024-11-14 | 2024-11-14 | View Filing |
| 8-K | 2024-11-13 | 2024-11-13 | View Filing |
| 10-Q | 2024-11-13 | 2024-11-13 | View Filing |
| S-8 | 2024-11-06 | 2024-11-06 | View Filing |
| SC 13D/A | 2024-10-31 | 2024-10-31 | View Filing |
| SC 13D/A | 2024-10-31 | 2024-10-31 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
| 4 | 2024-10-04 | 2024-10-04 | View Filing |
Algorithm Performance
Upgrade To Premium for Full Access
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|